Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury.

Simmon, Vincent F; (2009) Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury. Trials, 10 (1). 110-. ISSN 1745-6215 DOI: https://doi.org/10.1186/1745-6215-10-110

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/1745-6215-10-110

Abstract

Share

Download

Published Version Download

Filename: 111

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar

Google Scholar
Report this Record Edit item (admin only) View this record in elements